Antibiotic Development Incentive Menu: Options Getting Longer

Congress continues to look at ways to stimulate more research on anti-infectives. The list of potential incentives gets longer each time another drug category wins a new form of incentive. None of the ideas has succeeded yet in coalescing a political consensus; but potential legislative vehicles are out there.

By Laura Helbling

Innovation in the anti-infective category may be lagging, but there is no lack of innovation when it comes to proposals...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet